Felipe Couñago, National Clinical Director of GenesisCare Spain, shared on LinkedIn:
“Two prospective MR-guided adaptive radiotherapy studies accepted in ctRO – Clinical and Translational Radiation Oncology!
Title: Early outcomes of online adaptive MR-guided SBRT for localized prostate cancer: a prospective study
Authors: Abrahams Ocantoa, María Gonzáleza, Macarena Tejaa, Gloria Guardiaa, Gloria Sáncheza, Daniela Gonsalvesa, Castalia Fernándeza, Lisselott Torresa, Luis Glaríab, Israel Thuissarde, Miren Gaztañagaa, José Garcíag, Sigfredo Elías Romero Zhogbih, Jon Andreescui, Álvaro Floresj, Maia Dzhugashvilia, David Estebank, Evita Kruminal, Loubna Aakim, Jaume Fernándezn, José Gonzálezo, Antonio Ristorip, José Begaraq, Daniel Rivasq, Jasuani Bravor, Ana Vílchezs, Luis Clementet, Juan Martínez-Salamancau, Luca Nicosiav, Filippo Alongiv, Andrew Loblawx, Fernando López-Camposa, Felipe Couñagoa
Title: MRI-guided adaptive stereotactic body radiotherapy for the prostate bed: a prospective study of safety, tolerability, and patient-reported quality-of-life outcomes
Authors: Daniela Gonsalves Pieretti, Fernando López Campos, Abrahams Ocanto, Maria González, Lisselott Torres, Castalia Fernandez, Gloria Sanchez, Gloria Guardia, Alvaro Florese, Jon Andreescu, Laura Viduera, Dulce Urias, Ofelia Cabanes, Julia Rogriguez, Sigfredo Romero, Jose Antonio González, Miren Gaztañaga, Luis Glaria, Maia Dzhugashvili, Stefano Arcangeli, Federica Ferrario, Juan Ignacio Martinez Salamanca, Giulio Francolini, Felipe Couñago
Delighted to share that two prospective studies from our MR-Linac program have been accepted for publication in Clinical and Translational Radiation Oncology.
These represent the first prospective Spanish studies on online adaptive MR-guided SBRT for localized prostate cancer and the prostate bed.
Congratulations to Daniela Gonsalves Pieretti and Abrahams Ocanto Martínez for leading these outstanding projects, and to all co-authors for making this possible.
Most importantly, thank you to our patients and their families for their trust.”
Other articles about Radiation Oncology and prostate cancer on OncoDaily.
